David, a leading economist, warns that Israel’s future depends on urgent education reforms, with the next election potentially its last chance. 'We might not get another chance to turn this train ...
A regimen based on Jazz Pharma and PharmaMar's Zepzelca and Roche's Tecentriq has been approved in the US as a maintenance therapy for extensive-stage small-cell lung cancer (ES-SCLC). The approval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback